TWi Biotechnology, Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported net loss was TWD 76.18 million compared to TWD 15.3 million a year ago. Basic loss per share from continuing operations was TWD 1.13 compared to TWD 0.23 a year ago.

Diluted loss per share from continuing operations was TWD 1.13 compared to TWD 0.23 a year ago.